[1]
2017. The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. Swiss Medical Weekly. 147, 4950 (Dec. 2017), w14563. DOI:https://doi.org/10.4414/smw.2017.14563.